Description

Combination products include therapeutic or diagnostic products that combine a drug or biologic with a drug delivery device. According to a report by StrategyHelix, the global combination products market is set to increase by US$ 45.60 billion during 2022-2028, growing at a CAGR of 6.8% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for combination products. The global combination products market is segmented on the basis of product, application, and region. On the basis of product, the global combination products market has been segmented into drug/biologic-device combination products, drug-biologic combination products, and drug-device-biologic combination products. By application, the global combination products market has been segmented into cardiovascular, diabetes, cancer treatment, respiratory diseases, and others. Geographically, the global combination products market is segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America.

The global combination products market is highly competitive. The report also includes the profiles of leading companies such as Abbott Laboratories, B. Braun Melsungen AG, Becton Dickinson and Company, Boston Scientific Corporation, Cipla Limited, CosMED Pharmaceutical Co. Ltd., Enable Injections Inc., Johnson & Johnson, Medtronic plc, Novo Nordisk A/S, Sanofi S.A., Smith & Nephew plc, Stryker Corporation, Terumo Corporation, The 3M Company, Ypsomed AG.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the combination products market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: drug/biologic-device combination products, drug-biologic combination products, and drug-device-biologic combination products
Application: cardiovascular, diabetes, cancer treatment, respiratory diseases, and others
Region: North America, Asia Pacific, Europe, Middle East and Africa, and Latin America
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global combination products market
– Pinpoint growth sectors and trends for investment

Table of Contents

1. Market definition
2. Research methodology
3. Market data and outlook
3.1 Market size estimates
3.2 Forecast
4. Combination products market by product
4.1 Drug/biologic-device combination products
4.2 Drug-biologic combination products
4.3 Drug-device-biologic combination products
5. Combination products market by application
5.1 Cardiovascular
5.2 Diabetes
5.3 Cancer treatment
5.4 Respiratory diseases
5.5 Others
6. Combination products market by region
6.1 North America
6.2 Asia Pacific
6.3 Europe
6.4 Middle East and Africa
6.5 Latin America
7. Company profiles
7.1 Abbott Laboratories
7.2 B. Braun Melsungen AG
7.3 Becton, Dickinson and Company
7.4 Boston Scientific Corporation
7.5 Cipla Limited
7.6 CosMED Pharmaceutical Co., Ltd.
7.7 Enable Injections, Inc.
7.8 Johnson & Johnson
7.9 Medtronic plc
7.10 Novo Nordisk A/S
7.11 Sanofi S.A.
7.12 Smith & Nephew plc
7.13 Stryker Corporation
7.14 Terumo Corporation
7.15 The 3M Company
7.16 Ypsomed AG
8. Appendix
8.1 About StrategyHelix
8.2 Disclaimer